Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1990 Jun 1;142(11):1241–1244.

Lead exposure among mothers and their newborns in Toronto.

G Koren 1, N Chang 1, R Gonen 1, J Klein 1, L Weiner 1, H Demshar 1, S Pizzolato 1, I Radde 1, J Shime 1
PMCID: PMC1452610  PMID: 2344577

Abstract

Recent studies have suggested that a fetal blood lead level of 0.48 mumol/L (much lower than 1.21 mumol/L, which is the level previously believed to be toxic to the developing brain) may impair brain development permanently. We measured the maternal and umbilical cord blood levels of lead and free erythrocyte protoporphyrin (FEP) among 95 consecutive mother-infant pairs to determine whether neonates in Toronto are in the high-risk group. There was a significant correlation between the maternal and the cord blood lead levels (r = 0.59, p less than 0.0001). Most (99%) of the infants had cord blood lead levels below 0.34 mumol/L; in 11 cases the levels were below the detection limit of 0.01 mumol/L. The cord blood FEP levels were higher than the maternal levels. The US Centers for Disease Control, Atlanta, currently finds acceptable a blood FEP level of 0.62 mumol/L among children up to 10 years of age; however, this is not applicable to newborns since their higher FEP levels apparently reflect immature heme synthesis and increased erythrocyte volume rather than lead poisoning. Our data suggest that living in Toronto does not impose increased teratogenic risk from intrauterine exposure to lead; however, residents in high-risk areas should be followed up.

Full text

PDF
1241

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellinger D., Leviton A., Waternaux C., Needleman H., Rabinowitz M. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med. 1987 Apr 23;316(17):1037–1043. doi: 10.1056/NEJM198704233161701. [DOI] [PubMed] [Google Scholar]
  2. Koren G., Bologa M., Long D., Feldman Y., Shear N. H. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol. 1989 May;160(5 Pt 1):1190–1194. doi: 10.1016/0002-9378(89)90186-5. [DOI] [PubMed] [Google Scholar]
  3. Koren G., Feldman Y., Shear N. Motherisk--a new approach to antenatal counselling of drug/chemical exposure. Vet Hum Toxicol. 1986 Dec;28(6):563–565. [PubMed] [Google Scholar]
  4. McMichael A. J., Baghurst P. A., Wigg N. R., Vimpani G. V., Robertson E. F., Roberts R. J. Port Pirie Cohort Study: environmental exposure to lead and children's abilities at the age of four years. N Engl J Med. 1988 Aug 25;319(8):468–475. doi: 10.1056/NEJM198808253190803. [DOI] [PubMed] [Google Scholar]
  5. Moore M. R., McIntosh M. J., Bushnell I. W. The neurotoxicology of lead. Neurotoxicology. 1986 Summer;7(2):541–556. [PubMed] [Google Scholar]
  6. Wang S. T., Pizzolato S., Peter F. Microsampling technique and determination of blood lead by Zeeman atomic absorption spectrophotometry. Sci Total Environ. 1988 Apr;71(1):37–43. doi: 10.1016/0048-9697(88)90295-1. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES